'Practical and helpful clerks" provide a "smooth and personable service.'
Chambers and Partners 2011
'An incredibly good set for IP matters'.
Legal 500 2010
'8 New Square successfully parlays its renowned IP expertise into success in the IT sector.'
Chambers & Partners (Information Technology) 2009
'excellence on IT matters'
Legal 500 (Information Technology) 2010
'outstanding IP chambers'
Legal 500 2008
'clerking team that exhibits 'perfect communication''
Legal 500 2008
'A veritable powerhouse of IP expertise'
Chambers and Partners 2011
'A number of great IT and telecoms barristers.'
Legal 500 2010
'Top drawer IP set.'
Legal 500 2010
Novartis AG v Dexcel Pharma Limited [2008] EWHC 1266 (Pat)
Case Summary | Judgment | 10 June 2008
In June 2008, Daniel Alexander QC and Mark Chacksfield acted for Novartis in obtaining an interim injunction in a patent dispute concerning one of Novartis’ leading products, NEORAL®, a cyclosporin formulation. The case involved the question of the extent to which the court was bound by an earlier court’s approach to interpretation of the claims and Mr Justice Floyd handed down judgment in June 2008.